Anzeige
Mehr »
Login
Mittwoch, 28.09.2022 Börsentäglich über 12.000 News von 675 internationalen Medien
Wo es gerade richtig läuft!? – Wo kann man jetzt Geld verdienen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.09.AstraZeneca's COVID-19 treatment granted EC approval
21.09.BeiGene's Brukinsa gets green light from NICE as Waldenström's macroglobulinemia treatment
21.09.bluebird bio's Skysona approved by FDA to treat cerebral adrenoleukodystrophy
21.09.Tiziana's Foralumab shows promise in second patient with secondary progressive MS
20.09.Creating patient support programmes that help patients thrive
20.09.AstraZeneca/Sanofi's Beyfortus receives CHMP recommendation for prevention of RSV disease in infants
20.09.Roche's Vabysmo receives EC approval to treat two leading causes of vision loss
20.09.Otsuka's Lupkynis granted EC approval as active lupus nephritis treatment
20.09.Bristol Myers Squibb's Opdivo shows promise as adjuvant melanoma treatment
20.09.Tiziana announces Brigham and Women's hospital will receive ALS Association grant
16.09.Patient support programmes: providing meaningful care when you dare to treat rare
16.09.AstraZeneca's COVID-19 treatment receives CHMP recommendation for use in EU
16.09.Gilead's Veklury WHO recommendation expanded for treatment of severe COVID-19
16.09.YouGov survey shows global health systems 'unfit to cope' with another pandemic
16.09.Pfizer's investigational meningococcal vaccine shows promise in phase 3 trial
16.09.Neuron23 and QIAGEN partner to develop companion diagnostic for Parkinson's disease
15.09.The value of patient reported outcomes
15.09.FDA and NIHR launch public-private partnership for rare neurodegenerative diseases
15.09.Pfizer doses first patients with mRNA-based influenza vaccine
15.09.Novavax's COVID-19 vaccine candidate receives EC approval for use as a booster
15.09.WHO/Europe urges member states to endorse cervical cancer elimination roadmap
15.09.Locus Biosciences announces first patient treated in urinary tract infection trial
15.09.Havas Health & You appoints Laura Mizrahi as chief creative officer of H4B Chelsea
14.09.Thriving, not surviving - a hybrid mentality
14.09.Novartis announces $300m investment to boost development of next-generation biotherapeutics